HPV screening for women aged 23-29
Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
This study tests if using HPV screening can better protect women aged 23-29 from cervical cancer compared to the usual method of checking cells.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180000 (estimated) |
| Ages | 23 Years to 29 Years |
| Sex | Female |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 2 sites (Lund, Skåne County and 1 other locations) |
| Trial ID | NCT05229679 on ClinicalTrials.gov |
What this trial studies
This trial investigates whether organized screening using primary HPV analysis offers better cancer protection for women aged 23-29 compared to the traditional method of cytology. The study will involve women born between 1991 and 1997 in the Stockholm and Skåne regions of Sweden. Participants will undergo cell sampling and analysis to determine the effectiveness of HPV testing in preventing cervical cancer and related conditions.
Who should consider this trial
Good fit: Ideal candidates are women aged 23-29 who are invited for cervical cancer screening.
Not a fit: Women who do not attend the screening or do not provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance cervical cancer prevention for young women.
How similar studies have performed: Previous studies have shown promising results with HPV-based screening approaches, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ages 23-29 invited to screening. Exclusion Criteria: * Women who do not show up for screening or do not consent.
Where this trial is running
Lund, Skåne County and 1 other locations
- Region of Skåne — Lund, Skåne County, Sweden (Active_not_recruiting)
- Region Stockholm — Stockholm, Sweden (Recruiting)
Study contacts
- Principal investigator: Joakim Dillner, MD, PhD — Karolinska University Hospital/Karolinska Institutet
- Study coordinator: Joakim Dillner, MD, PhD
- Email: joakim.dillner@ki.se
- Phone: +46 (0) 72-468 24 60
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.